Compensation to patient [Regulatives / Guidelines]

posted by Pharma_88 – India, 2025-01-22 14:02 (514 d 15:02 ago) – Posting: # 24344
Views: 4,997

Dear All,

For Bioequivalence study conducted on patients, do we need to provide financial compensation to patients for the participation i.e. Housing or blood loss for Pharmacokinetic evaluation? any guideline from DCGI/ICMR or any regulatory body?

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
153 visitors (0 registered, 153 guests [including 28 identified bots]).
Forum time: 06:04 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5